Welcoming Our New Board Member: Dr. Christopher Bown
The CABI Board of Directors would like to welcome its newest member, Dr. Christopher Bown. Dr. Bown is a patent agent in Gowlings' Ottawa office, practising in Intellectual Property. He prepares and prosecutes patent applications in all areas of the life sciences and chemical fields, especially those involving biotechnology, pharmaceuticals, diagnostics, bioprocessing, and medical devices. He is a registered Patent Agent in both Canada and the United States.
Dr. Bown obtained his PhD from the Department of Medical Sciences at McMaster University and his BSc (Hons) from the University of Western Ontario. His postdoctoral research at the Neuroscience Research Institute in Ottawa focused on the transcriptional regulation of the genes encoding proteins involved in neurotransmission.
Dr. Bown assists entrepreneurs and SMEs, as well as multinational corporations, in the protection and management of their IP assets. In addition to Dr. Bown's main practice areas, he has experience in a wide variety of different disciplines, including oil and gas extraction technologies, viniculture, radio transmission technologies, cosmetic chemistry, and inventions related to aerospace and defense.
Dr. Bown brings a wealth of knowledge and experience to CABI. Please join CABI in congratulating our newest board member.